These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9872000)

  • 21. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic sensitivity of opportunistic bacteria isolated from patients].
    Arons RM; Chursina TV; Shub GM; Kontareva KIu
    Antibiotiki; 1982; 27(7):517-21. PubMed ID: 7137975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan.
    Ahmed AA; Osman H; Mansour AM; Musa HA; Ahmed AB; Karrar Z; Hassan HS
    Am J Trop Med Hyg; 2000; 63(5-6):259-63. PubMed ID: 11421374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: results of an Italian multicenter survey.
    Schito GC; Chezzi C; Nicoletti G; Moreddu M; Arcangeletti MC; Stefani S; Albini E; Del Bono GP
    Infection; 1992; 20 Suppl 4():S291-5. PubMed ID: 1294520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New Enterobacteriaceae found in medical bacteriology Moellerella wisconsensis, Koserella trabulsii, Leclercia adecarboxylata, Escherichia fergusonii, Enterobacter asbutiae, Rahnella aquatilis].
    Richard C
    Ann Biol Clin (Paris); 1989; 47(5):231-6. PubMed ID: 2742218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
    Marumo K; Nakamura Y; Fukuda S
    Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential.
    Starcic Erjavec M; Rijavec M; Krizan-Hergouth V; Fruth A; Zgur-Bertok D
    Int J Antimicrob Agents; 2007 Nov; 30(5):436-42. PubMed ID: 17719751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin].
    Hernández MS; García JA; Muñoz JL
    Rev Esp Quimioter; 2009 Mar; 22(1):25-9. PubMed ID: 19308743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
    Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
    Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report.
    Kahlmeter G
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():15-22; discussion 63-5. PubMed ID: 11051619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance and plasmid profiles of urinary Escherichia coli isolates from Jordanian patients.
    Shehabi AA; Mahafzah AM; Al-Khalili KZ
    East Mediterr Health J; 2004 May; 10(3):322-8. PubMed ID: 16212208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.
    Muratani T; Matsumoto T
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S10-3. PubMed ID: 16829056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
    Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
    Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.
    Karageorgopoulos DE; Wang R; Yu XH; Falagas ME
    J Antimicrob Chemother; 2012 Feb; 67(2):255-68. PubMed ID: 22096042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli.
    Schumacher A; Steinke P; Bohnert JA; Akova M; Jonas D; Kern WV
    J Antimicrob Chemother; 2006 Feb; 57(2):344-8. PubMed ID: 16354746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary tract infections associated with multidrug resistant enteric bacilli: characterization and genetical studies.
    Noor N; Ajaz M; Rasool SA; Pirzada ZA
    Pak J Pharm Sci; 2004 Jul; 17(2):115-23. PubMed ID: 16414603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of the culture medium in the sensitivity of Gram-negative stocks and their resistant mutants to fosfomycin. The influence of glucose-6-phosphate].
    Drugeon H; Courtieu AL
    Minerva Med; 1978 Dec; 69(59):4055-60. PubMed ID: 105326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.